These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31390017)

  • 1. Cardioversion as bystander in atrial fibrillation-related thrombo-embolism.
    Verheugt FWA
    Eur Heart J; 2019 Sep; 40(36):3033-3034. PubMed ID: 31390017
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
    Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.
    Black IW; Fatkin D; Sagar KB; Khandheria BK; Leung DY; Galloway JM; Feneley MP; Walsh WF; Grimm RA; Stollberger C
    Circulation; 1994 Jun; 89(6):2509-13. PubMed ID: 8205657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we assess the risk of embolic complications of cardioversion?
    Gackowski A; Stąpór M
    Pol Arch Med Wewn; 2016; 126(1-2):5-6. PubMed ID: 26842373
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic changes after cardioversion of chronic atrial fibrillation.
    Upshaw CB
    Arch Intern Med; 1997 May; 157(10):1070-6. PubMed ID: 9164372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The thromboembolic risk of atrial fibrillation].
    Vandenbossche JL
    Rev Med Brux; 1999 Sep; 20(4):A233-6. PubMed ID: 10523898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thromboembolism after cardioversion of recent-onset atrial fibrillation: brief is not always safe.
    Dagres N; Kornej J; Hindricks G
    J Am Coll Cardiol; 2013 Sep; 62(13):1193-4. PubMed ID: 23850931
    [No Abstract]   [Full Text] [Related]  

  • 9. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
    Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
    J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of atrial fibrillation. New concepts, new strategies].
    Lardoux H; Lechat P; Isnard R
    Presse Med; 1995 Dec; 24(38):1820-3. PubMed ID: 8545434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Själander S; Svensson PJ; Friberg L
    Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Renda G; Zimarino M; Ricci F; Piccini JP; Ezekowitz MD; Patel MR; Cappato R; Giugliano RP; De Caterina R
    Am J Med; 2016 Oct; 129(10):1117-1123.e2. PubMed ID: 27262782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peri-operative management of atrial fibrillation.
    Nathanson MH; Gajraj NM
    Anaesthesia; 1998 Jul; 53(7):665-76. PubMed ID: 9771175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Renda G; Ricci F; De Caterina R
    Am J Med; 2017 Apr; 130(4):457-461. PubMed ID: 27751896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism after cardioversion for atrial fibrillation.
    Cheng TO
    Ann Intern Med; 1997 Dec; 127(11):1039; author reply 1039-40. PubMed ID: 9412288
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboembolism after cardioversion for atrial fibrillation.
    Federman DG
    Ann Intern Med; 1997 Dec; 127(11):1039; author reply 1039-40. PubMed ID: 9412289
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours.
    Weigner MJ; Caulfield TA; Danias PG; Silverman DI; Manning WJ
    Ann Intern Med; 1997 Apr; 126(8):615-20. PubMed ID: 9103128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation.
    Josephson RA
    Circulation; 1994 Dec; 90(6):3122. PubMed ID: 7994866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.